Samantha McLemore - Patient Capital Management
Holding/activity history for Teva Pharmaceutical Industries Ltd. (TEVA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price |
| 2024 Q3 | 100,000 | 0.09 | $18.02 | ||
| 2024 Q2 | 100,000 | 0.09 | $16.25 | ||
| 2024 Q1 | 100,000 | 0.07 | $14.11 | ||
| 2023 Q4 | 100,000 | 0.06 | Reduce 20.00% | 0.02 | $10.44 |
| 2023 Q3 | 125,000 | 0.08 | Reduce 59.16% | 0.12 | $10.20 |
| 2023 Q2 | 306,054 | 0.13 | Reduce 51.11% | 0.14 | $7.53 |
| 2023 Q1 | 626,000 | 2.49 | Reduce 24.81% | 0.82 | $8.85 |
| 2022 Q4 | 832,575 | 3.75 | Reduce 29.14% | 1.54 | $9.12 |
| 2022 Q3 | 1,175,000 | 4.81 | Reduce 1.50% | 0.07 | $8.07 |
| 2022 Q2 | 1,192,950 | 4.40 | Add 19.19% | 0.71 | $7.52 |
| 2022 Q1 | 1,000,850 | 3.71 | Add 33.46% | 0.93 | $9.39 |
| 2021 Q4 | 749,900 | 2.43 | $8.01 |